Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment o... Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -6.26 | -1.67124969966 | 374.57 | 382.13 | 364.52 | 234053 | 373.17348587 | CS |
| 4 | 54.19 | 17.2513689036 | 314.12 | 382.535 | 312.25 | 402320 | 353.32471885 | CS |
| 12 | 101.39 | 37.9851640941 | 266.92 | 382.535 | 251.97 | 317252 | 317.47942549 | CS |
| 26 | 113.8 | 44.7133707909 | 254.51 | 382.535 | 242.0001 | 298807 | 292.5072754 | CS |
| 52 | 225.01 | 157.020237264 | 143.3 | 382.535 | 130.5002 | 310939 | 233.06560107 | CS |
| 156 | 247.62 | 205.170270942 | 120.69 | 382.535 | 93.95 | 312176 | 179.46192906 | CS |
| 260 | 299.66 | 436.504005827 | 68.65 | 382.535 | 38.8563 | 277045 | 145.85892313 | CS |
rynlrt
5年前
Fofo812
5年前
rynlrt
5年前
Fofo812
5年前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。